Back to funds
View filing
INVESTOR AB
hedge fundUpdated 27 days agoManaged by Investor Ab • Latest filing Q2 2026
Portfolio value
$14.4B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
23.4%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $3.2B |
| Q2 2023 | $2.9B |
| Q3 2023 | $2.8B |
| Q4 2023 | $3.4B |
| Q1 2024 | $3.7B |
| Q2 2024 | $3.5B |
| Q3 2024 | $4.3B |
| Q4 2024 | $4.5B |
| Q1 2025 | $4.4B |
| Q2 2025 | $5.2B |
| Q3 2025 | $5.2B |
| Q4 2025 | $5.7B |
| Q1 2026 | $15.1B |
| Q2 2026 | $14.4B |
Top holdings
7 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AZN ASTRAZENECA PLC | $9.8B | 51.59M | 67.92% | — |
| 2 | N NDAQ NASDAQ INC | $4.6B | 58.44M | 31.98% | — |
| 3 | M MDWD MEDIWOUND LTD | $12.8M | 872.1K | 0.09% | — |
| 4 | C CLBT CELLEBRITE DI LTD | $1.1M | 75.0K | 0.01% | — |
| 5 | M MU MICRON TECHNOLOGY INC | $543K | 470 | 0.00% | — |
| 6 | V VZ VERIZON COMMUNICATIONS INC | $478K | 11.3K | 0.00% | — |
| 7 | B BMRN BIOMARIN PHARMACEUTICAL INC | $212K | 3.7K | 0.00% | — |